- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
18 result(s) found for: Shoulder Girdle.
Displaying page 1 of 1.
EudraCT Number: 2004-000622-67 | Sponsor Protocol Number: 3147K2-101WW | Start Date*: 2005-06-03 |
Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc. | ||
Full Title: A Double-Blind, Placebo-Controlled, Randomized, Multiple Ascending Dose, Safety Study of MYO-029 Administered to Adult Patients with Becker, Facioscapulohumeral and Limb-Girdle Muscular Dystrophy. | ||
Medical condition: Becker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Limb-Girdle Muscular Dystrophy. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001502-42 | Sponsor Protocol Number: B9R-US-GDGH | Start Date*: 2016-06-23 | |||||||||||
Sponsor Name:Eli Lilly and Company Limited | |||||||||||||
Full Title: Effect of Early Growth Hormone Treatment on Long-term Growth and Skeletal Maturation in Girls With Turner Syndrome | |||||||||||||
Medical condition: Turner Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004740-36 | Sponsor Protocol Number: PTCEMF-GD-004 | Start Date*: 2019-10-14 | |||||||||||
Sponsor Name:PTC Therapeutics, Inc. | |||||||||||||
Full Title: A MULTICENTER RANDOMIZED PLACEBO-CONTROLLED PHASE 3 STUDY ON THE SAFETY AND EFFICACY OF DEFLAZACORT (EMFLAZA®) IN SUBJECTS WITH LIMB-GIRDLE MUSCULAR DYSTROPHY 2I (LGMD2I | |||||||||||||
Medical condition: Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) FR (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002427-40 | Sponsor Protocol Number: 2602 | Start Date*: 2007-11-08 |
Sponsor Name:Newcastle Upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: What is the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin? | ||
Medical condition: Upper limb spasticity following stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004990-42 | Sponsor Protocol Number: PMR-SPARE | Start Date*: 2017-09-26 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Innere Medizin III, Klinische Abteilung für Rheumatologie | ||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects with New-Ons... | ||
Medical condition: Polymyalgia rheumatica Polymyalgia rheumatica is an inflammatory rheumatic disease that occurs primarily in the elderly with a peak incidence around 70 years of age. It is clinically characteriz... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001019-26 | Sponsor Protocol Number: 202000167 | Start Date*: 2021-02-26 |
Sponsor Name:University Medical Center Groningen, Department of Rheumatology and Clinical Immunology | ||
Full Title: [18F]fluor-PEG-folate PET/CT imaging in Giant Cell Arteritis: a pilot study. | ||
Medical condition: giant cell arteritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000648-23 | Sponsor Protocol Number: M20-370 | Start Date*: 2021-09-23 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid... | |||||||||||||
Medical condition: Subjects with Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) HU (Prematurely Ended) NL (Completed) IT (Prematurely Ended) PL (Prematurely Ended) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002822-28 | Sponsor Protocol Number: 11034 | Start Date*: 2023-06-01 |
Sponsor Name:University Medical Center Groningen, Department of Rheumatology and Clinical Immunology | ||
Full Title: CD8 T cell imaging by positron emission tomography with 89Zr-Df-IAB22M2C in giant cell arteritis and rheumatoid arthritis: a pilot study | ||
Medical condition: giant cell arteritis and rheumatoid arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001758-14 | Sponsor Protocol Number: 201677 | Start Date*: 2015-12-18 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Limited | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Patients with Giant Cell Arteritis | |||||||||||||
Medical condition: Giant Cell Arteritis (GCA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Prematurely Ended) NL (Prematurely Ended) BG (Prematurely Ended) HU (Prematurely Ended) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002353-57 | Sponsor Protocol Number: LOD3501 | Start Date*: 2013-02-25 | |||||||||||
Sponsor Name:Mundipharma Research Limited | |||||||||||||
Full Title: A randomised, multi-centre, double-blind, active-controlled, parallel group study to assess the efficacy and safety of modified release prednisone (Lodotra®) compared to immediate release prednison... | |||||||||||||
Medical condition: polymyalgia rheumatica | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) CZ (Prematurely Ended) GB (Prematurely Ended) HU (Prematurely Ended) ES (Completed) DK (Prematurely Ended) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006022-25 | Sponsor Protocol Number: WA28119 | Start Date*: 2013-05-05 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF TOCILIZUMAB IN SUBJECTS WITH GIANT CELL ARTERITIS | |||||||||||||
Medical condition: Giant cell arteritis (GCA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) SE (Completed) AT (Completed) DE (Completed) DK (Completed) GB (Completed) PT (Completed) NL (Completed) ES (Completed) BE (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004809-31 | Sponsor Protocol Number: CAIN457R12301 | Start Date*: 2021-09-24 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, parallel-group, double-blind, placebo-controlled, multicenter Phase III trial to investigate the efficacy and safety of secukinumab 300 mg administered subcutaneously versus placeb... | |||||||||||||
Medical condition: giant cell arteritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) BE (Ongoing) NO (Ongoing) PT (Ongoing) DE (Ongoing) FI (Temporarily Halted) DK (Ongoing) BG (Temporarily Halted) SE (Restarted) IT (Ongoing) GR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001360-39 | Sponsor Protocol Number: SU2C-SARC032 | Start Date*: 2019-06-24 | ||||||||||||||||
Sponsor Name:SARC | ||||||||||||||||||
Full Title: A Phase II Randomized Controlled Trial of Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab in Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity | ||||||||||||||||||
Medical condition: This trial investigates whether neoadjuvant radiotherapy combined with pembrolizumab followed by surgical resection and adjuvant pembrolizumab improves disease-free survival for patients with high-... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002622-24 | Sponsor Protocol Number: CAIN457R1DE01 | Start Date*: 2022-06-09 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A randomized, parallel-group, double-blind, placebo-controlled, multicenter trial to investigate the efficacy and safety of subcutaneously administered secukinumab in patients with new-onset of gia... | |||||||||||||
Medical condition: Giant Cell Arteritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002826-22 | Sponsor Protocol Number: BONNOTTE-PHRCN-2017 | Start Date*: 2019-03-07 | |||||||||||
Sponsor Name:CHU Dijon Bourgogne | |||||||||||||
Full Title: MEthotrexate versus TOcilizumab for treatment of GIant cell Arteritis: a multicenter, randomized, controlled trial | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002989-42 | Sponsor Protocol Number: EFC15160 | Start Date*: 2018-11-29 | |||||||||||
Sponsor Name:Sanofi-Aventis Recherche & Développement | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with polymyalgia rheumatica | |||||||||||||
Medical condition: Polymyalgia rheumatica | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) DE (Completed) BE (Prematurely Ended) FR (Prematurely Ended) HU (Completed) GB (GB - no longer in EU/EEA) EE (Prematurely Ended) NL (Completed) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001003-36 | Sponsor Protocol Number: KPL-301-C001 | Start Date*: 2018-07-09 | |||||||||||
Sponsor Name:Kiniksa Pharmaceuticals, Ltd. (Hamilton, Bermuda) c/o Kiniksa Pharmaceuticals Corp. | |||||||||||||
Full Title: A Phase 2, randomized, double-blind placebo-controlled study to test the efficacy and safety of KPL-301 in giant cell arteritis | |||||||||||||
Medical condition: giant cell arteritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) GB (GB - no longer in EU/EEA) DE (Completed) ES (Completed) NL (Completed) BE (Completed) SI (Completed) IT (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002610-12 | Sponsor Protocol Number: CAIN457ADE11C | Start Date*: 2018-12-06 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A randomized, parallel-group, double-blind, placebo-controlled, multicenter phase 2 trial to investigate the safety and efficacy of secukinumab (AIN457) in patients with giant cell arteritis (TitAIN) | |||||||||||||
Medical condition: Giant Cell Arteritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.